Clinical Trial Results: Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating 0.25% timolol gel for improving healing and cosmetic outcomes after full-thickness skin grafting; study terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Wound
• Wound Healing
• Wound of Skin

Drugs mentioned

• timolol gel 0.25% (timolol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Wound of Skin, Wound Heal | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2026-06-09